Identity
- Trade Name
- buddy lite AC Blood/Fluid Warmer FDA UDI
- Generic Name
- Conduction blood/fluid warmer FDA UDI
- Model / Reference
- 905-00022 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 10896128002449 FDA UDI
- 510(k) Number
- K112639 FDA UDI
- FDA Product Code
- BSB FDA UDI
- GMDN Term
- Conduction blood/fluid warmer FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 864.9205 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
MR Unsafe FDA UDI
Category: Conduction blood/fluid warmer
buddy lite AC Blood/Fluid Warmer by Belmont Instrument Corp. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Conduction blood/fluid warmer.
- Ranger™ — 3M COMPANY · Class II
- ThermaCor 1200 Infusion System — Smisson-Cartledge Biomedical, LLC · Class II
- Curaplex — BOUND TREE MEDICAL, LLC · Class II
- ASTOLINE — Stihler Electronic GmbH · Class II
- ASTOTHERM® PLUS — Stihler Electronic GmbH · Class II
- EXPRESS FLUID WARMER — NxStage Medical, Inc. · Class II
- °M Warmer System - Charger — Mequ A/S · Class II
- ASTOFLO® PLUS ECO — Stihler Electronic GmbH · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Belmont Instrument Corp.
Sources (1)
- FDA UDI 442bfb3c-9fa7-486f-9858-7c858d0fdf75 33 fields · synced Jun 8, 2026